Viewing Study NCT00514267

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-02-20 @ 6:42 PM
Study NCT ID: NCT00514267
Status: COMPLETED
Last Update Posted: 2015-08-13
First Post: 2007-08-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors
Sponsor: Astellas Pharma Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
None Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Prostate Cancer View
None HRPC View
None Hormone Refractory Prostate Cancer View
None YM155 View
None Treatment Outcome View
None Solid Tumors View